Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Gut and Liver ; : 126-128, 2012.
Article in English | WPRIM | ID: wpr-211728

ABSTRACT

Hereditary fructose intolerance is an autosomal recessive disorder that is caused by a deficiency in fructose-1-phosphate aldolase (Aldolase B). Children can present with hypoglycemia, jaundice, elevated liver enzymes and hepatomegaly after intake of dietary fructose. Long-term intake of fructose in undiagnosed patients can result in hepatic failure or renal failure. We experienced a case of hereditary fructose intolerance presenting as recurrent hepatitis-like episodes. Detailed evaluation of her dietary habits revealed her avoidance of sweetened foods and fruits. Genetic analysis of ALDOB revealed that she is a homozygote for a novel frameshifting mutation c[758_759insT]+[758_759insT] (p.[val25 3fsX24]+[val253fsX24]). This report is the first of a Korean patient diagnosed with hereditary fructose intolerance using only molecular testing without undergoing intravenous fructose tolerance test or enzyme assay.


Subject(s)
Child , Humans , Enzyme Assays , Feeding Behavior , Frameshift Mutation , Fructose , Fructose Intolerance , Fructose-Bisphosphate Aldolase , Fructosephosphates , Fruit , Hepatitis , Hepatomegaly , Homozygote , Hypoglycemia , Jaundice , Liver , Liver Failure , Renal Insufficiency
2.
Acta Pharmaceutica Sinica ; (12): 1291-1300, 2011.
Article in Chinese | WPRIM | ID: wpr-232995

ABSTRACT

Fructose-1, 6-bisphosphatase (FBPase), a rate-limiting enzyme involved in the pathway of gluconeogenesis, can catalyze the hydrolysis of fructose-1, 6-bisphosphate to fructose-6-phosphate. Upon inhibiting the activity of FBPase, the production of endogenous glucose can be decreased and the level of blood glucose lowered. Therefore, inhibitors of FBPase are expected to be novel potential therapeutics for the treatment of type II diabetes. Recent research efforts were reviewed in the field of developing allosteric inhibitors interacting with the AMP binding site of FBPase.


Subject(s)
Animals , Humans , Adenosine Monophosphate , Chemistry , Allosteric Site , Binding Sites , Blood Glucose , Metabolism , Diabetes Mellitus, Type 2 , Blood , Enzyme Inhibitors , Chemistry , Pharmacology , Fructose-Bisphosphatase , Chemistry , Metabolism , Fructosediphosphates , Metabolism , Fructosephosphates , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL